Royalty Pharma plc
Sector
Location
Market Cap
USD 21.18 B
Share Price
USD 36.31
Avg Daily Volume
3,763,646
Change (1 day)
Change (1 year)
Change (YTD)
Investor AB (publ)
USD 30.39
INVE-B.ST
SBI Holdings, Inc.
USD 45.51
8473.T
BB Biotech AG
USD 40.19
BION.SW
Eli Lilly and Company
USD 709.82
LLY
AbbVie Inc.
USD 209.50
ABBV
Roche Holding AG
USD 339.30
RO.SW
Novartis AG
USD 127.19
NOVN.SW
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
AstraZeneca PLC
USD 150.15
AZN.L
Abbott Laboratories
USD 132.00
ABT
Merck & Co., Inc.
USD 86.08
MRK
Thermo Fisher Scientific Inc.
USD 483.76
TMO
Amgen Inc.
USD 295.76
AMGN
Pfizer Inc.
USD 25.74
PFE
Gilead Sciences, Inc.
USD 116.14
GILD
Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
---|
Investor AB (publ)
USD 30.39
INVE-B.ST
SBI Holdings, Inc.
USD 45.51
8473.T
BB Biotech AG
USD 40.19
BION.SW
Eli Lilly and Company
USD 709.82
LLY
AbbVie Inc.
USD 209.50
ABBV
Roche Holding AG
USD 339.30
RO.SW
Novartis AG
USD 127.19
NOVN.SW
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
AstraZeneca PLC
USD 150.15
AZN.L
Abbott Laboratories
USD 132.00
ABT
Merck & Co., Inc.
USD 86.08
MRK
Thermo Fisher Scientific Inc.
USD 483.76
TMO
Amgen Inc.
USD 295.76
AMGN
Pfizer Inc.
USD 25.74
PFE
Gilead Sciences, Inc.
USD 116.14
GILD